Enter Note Done
Go to previous page in this tab
Event
  • Scientific Session
  • Bookmark Icon
  • The Rewritable Liver: Environmental Exposures and the Erosion of Sexual Dimorphism
  • Schedule
    Notes
  • Stars at Night Ballroom B1‚ Convention Center
    Set Timezone


Chair: Colette Miller, US EPA
Co-Chair: Banrida Wahlang, University of Louisville

Primary Endorser: Mechanisms Specialty Section


Endorser(s): Women in Toxicology Special Interest Group


Endorser(s): Reproductive and Developmental Toxicology Specialty Section


Of the body's sexually dimorphic organs, the liver is among the most pronounced, with broad effects on xenobiotic and energy metabolism. These sex differences carry direct implications for human health risk assessment: conditions such as metabolic dysfunction-associated steatotic liver disease (MASLD) and hepatocellular carcinoma are observed at higher rates in males, and environmental exposures are increasingly recognized as key drivers of sex-divergent liver disease. Such noteworthy differences in diseases and pharmaceutical responses between the sexes has helped spur the NIH policy mandating study of 'Sex as a Biological Variable' in preclinical models. Since the policy's establishment in 2014, the evidence base on sex-specific liver responses to environmental stressors has expanded markedly, sharpening our understanding of where and why male and female livers diverge in their responses and disease outcomes. This session will cover the basics and mechanisms of hepatic sexual dimorphism, reviewing the fundamental signaling factors and metabolic pathways that underlay differential toxicity between the sexes. Building on this foundation, the session will examine how environmental exposures can perturb sex-specific hepatic regulatory programs, resulting in shifts toward feminized or masculinized liver phenotypes, and how these altered hepatic states influence mechanisms of toxicity, disease susceptibility, and opportunities for therapeutic intervention. Speakers will present novel yet underexplored concepts in liver toxicology, integrating how hepatic sexualization and de-sexualization may influence disease outcomes and inform risk assessment across chemical and environmental contexts.
Session and Activity Type
Presentations